Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07221877 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.
Track this trial| NCT Number | NCT07221877 |
| Lead Sponsor | Bristol-Myers Squibb |
| Conditions | Schizophrenia |
| Enrollment | 60 participants |
| Start Date | 2026-01-20 |
| Primary Completion | 2027-12-30 (estimated) |
| Study Completion | 2027-12-30 (estimated) |
| Updated on ClinicalTrials.gov | 2026-06-03 |